Last reviewed · How we verify
Paroxetine CR and Paroxetine IR — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Paroxetine CR and Paroxetine IR (Paroxetine CR and Paroxetine IR) — GlaxoSmithKline.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Paroxetine CR and Paroxetine IR TARGET | Paroxetine CR and Paroxetine IR | GlaxoSmithKline | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Paroxetine CR and Paroxetine IR CI watch — RSS
- Paroxetine CR and Paroxetine IR CI watch — Atom
- Paroxetine CR and Paroxetine IR CI watch — JSON
- Paroxetine CR and Paroxetine IR alone — RSS
Cite this brief
Drug Landscape (2026). Paroxetine CR and Paroxetine IR — Competitive Intelligence Brief. https://druglandscape.com/ci/paroxetine-cr-and-paroxetine-ir. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab